Avoidance of medical care among American Indians with a history of cancer during the coronavirus pandemic

• Published in: Frontiers in public health Vol. 11; p. 1265071
• Main Authors: Chen, Sixia, James, Shirley A, Hall, Spencer, Dang, Julie H, Campbell, Janis E, Chen, Jr, Moon S, Doescher, Mark P
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 2023
• Subjects: American Indian; American Indian or Alaska Native; appointment cancelations; cancer; coronavirus; COVID-19; COVID-19 - epidemiology; Cross-Sectional Studies; Humans; medical delays; Neoplasms - therapy; Pandemics; Patient Acceptance of Health Care; COVID-19; appointment cancelations; disparities; coronavirus; cancer; American Indian; medical delays
• ISSN: 2296-2565; 2296-2565
• DOI: 10.3389/fpubh.2023.1265071

Assess the percentage of cancer-related appointment delays, cancelations, and the unavailability of medications experienced by American Indian participants during the COVID-19 pandemic. This cross-sectional survey study was completed between October 2020 and July 2021 by 360 individuals with cancer who lived in California and Oklahoma. Binary and multivariate logistic regression analysis was completed in SAS 9.4. During the initial Covid-19 pandemic, almost one-third (30%) of respondents delayed cancer-related appointments, 42% canceled cancer-related appointments, and one-quarter (24%) were unable to access prescription medications or over-the-counter medications (27%) due to COVID-19. People who underwent testing for COVID-19 were five times more likely to delay a medical appointment [adjusted odds ratio (aOR) = 5.3, 95% CI:2.4, 11.7] and people who followed three or more social distancing measures were more than six times more likely to cancel medical appointments (aOR:6.3, 95% CI:2.9, 13.9). This study identifies delays, cancelations, and medication inaccessibility people identifying as American Indian faced during the coronavirus pandemic. Disparities in healthcare delivery could contribute to increased morbidity and mortality rates of cancer.